Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Firefly Aerospace Inc. due to allegations of misleading statements and operational issues that have negatively impacted the company's stock performance and investor confidence [4][6]. Group 1: Company Overview - Firefly Aerospace Inc. conducted its initial public offering (IPO) on August 7, 2025, selling 19.296 million shares at a price of $45.00 per share [7]. - The company reported a significant loss of $80.3 million, or $5.78 per share, for the second quarter of 2025, which is an increase from a loss of $58.7 million, or $4.60 per share, in the same quarter of 2024 [8]. Group 2: Financial Performance - Firefly's revenue for the second quarter of 2025 was $15.55 million, which fell short of analyst estimates of $17.25 million and represented a 26.2% decrease from the same quarter in 2024 [8]. - The revenue from Firefly's Spacecraft Solutions business segment was only $9.2 million, indicating a 49% year-over-year decrease [8]. Group 3: Stock Performance and Legal Implications - Following the financial results announcement, Firefly's stock price dropped by $7.58 per share, or 15.31%, closing at $41.94 on September 23, 2025 [9]. - After a subsequent announcement regarding a failure in the Alpha Flight 7 rocket test, the stock price fell further by $7.66 per share, or 20.73%, closing at $29.30 on September 30, 2025 [11]. Group 4: Legal Action and Class Action Details - A federal securities class action has been filed against Firefly, with a deadline of January 12, 2026, for investors to seek the role of lead plaintiff [4]. - The complaint alleges that Firefly and its executives made false statements regarding the demand for its offerings and the operational readiness of its rocket program, which could have a material negative impact on the company [6].

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding Skye's conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the Skye Bioscience class action, go to www.faruqilaw.com/SKYE or call Far ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against MoonLake (NASDAQ: MLTX) due to allegations of violations of federal securities laws, particularly concerning misleading statements about its product SLK compared to BIMZELX [3][5]. Group 1: Legal Investigation and Class Action - The firm is reminding investors of the December 15, 2025 deadline to seek the role of lead plaintiff in a federal securities class action against MoonLake [3]. - The complaint alleges that MoonLake and its executives made false and misleading statements regarding the efficacy and clinical benefits of SLK compared to traditional monoclonal antibodies [5]. - Investors who suffered losses between March 10, 2024, and September 29, 2025, are encouraged to contact the firm to discuss their legal options [1][8]. Group 2: Stock Performance and Impact - Following the announcement of disappointing results from the Phase 3 VELA program on September 28, 2025, MoonLake's stock price fell by $55.75 per share, or 89.9%, closing at $6.24 on September 29, 2025 [6]. - The results indicated that SLK did not demonstrate competitive efficacy relative to BIMZELX, which contributed to the significant drop in stock price [6]. Group 3: Company Background - Faruqi & Faruqi, LLP is a national securities law firm with a history of recovering hundreds of millions of dollars for investors since its founding in 1995 [4].

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Inspire Medical between August 6, 2024 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]New York, New York--(Newsfile Corp. - N ...

NEWTOWN, Pa. , Oct. 3, 2025 /PRNewswire/ -- Edelson Lechtzin LLP, a national class action law firm, is investigating potential violations of the federal securities laws involving CarMax, Inc. (NYSE: KMX), resulting from allegations of providing potentially misleading business information to the investing public. ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against CTO Realty Growth, Inc. due to allegations of misleading statements regarding the sustainability of dividends and financial practices [1][3]. Group 1: Allegations Against CTO - The complaint alleges that CTO and its executives violated federal securities laws by making false statements and failing to disclose that CTO's dividends were less sustainable than claimed [3]. - CTO is accused of using deceptive practices to inflate its Adjusted Funds From Operations (AFFO) and overstate the profitability of its Ashford Lane property [3]. - The Wolfpack Research report claims CTO has not generated enough cash to cover its recurring capital expenditures and dividends since converting to a REIT in 2021, relying instead on share dilution [4]. Group 2: Financial Impact - Following the release of the Wolfpack Report, CTO's stock price fell by $0.98, or 5.42%, closing at $17.10 per share on June 25, 2025 [5]. - The report highlighted that CTO has only $8.4 million in cash while facing quarterly dividends of $14 million and average recurring capital expenditures of $5.7 million [4]. Group 3: Legal Proceedings - Investors who suffered losses in CTO are encouraged to contact Faruqi & Faruqi to discuss their legal rights and the October 7, 2025 deadline to seek the role of lead plaintiff in a federal securities class action [1][6]. - The lead plaintiff is defined as the investor with the largest financial interest in the relief sought, who will oversee the litigation on behalf of the class [6].

Core Viewpoint - The law firm Kirby McInerney LLP is investigating Car-Mart, Inc. for potential violations of federal securities laws or other unlawful business practices [1] Group 1 - Car-Mart announced on July 15, 2025, that it would delay filing its annual report due to the need for enhanced disclosures related to loans [1]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Novo Nordisk A/S due to allegations of misleading statements regarding the company's growth potential and market capabilities, particularly related to its GLP-1 products [3][4]. Group 1: Legal Investigation - The law firm is encouraging investors who suffered losses exceeding $100,000 in Novo between May 7, 2025, and July 28, 2025, to contact them for discussing legal options [1]. - A federal securities class action has been filed against Novo, with a deadline of September 30, 2025, for investors to seek the role of lead plaintiff [1][5]. Group 2: Allegations Against Novo - The complaint alleges that Novo and its executives violated federal securities laws by making false or misleading statements and failing to disclose the true state of the company's growth potential [3]. - Specific claims include that Novo's potential to capitalize on the compounded market was greatly understated, and the likelihood of patients switching to Novo's branded alternatives was overstated [3]. Group 3: Stock Performance Impact - Following Novo's announcement of lowered sales and profit outlook on July 29, 2025, the company's stock price fell from $69.00 per share on July 28, 2025, to $53.94 per share on July 29, 2025, marking a decline of approximately 21.83% in one day [4].

Core Viewpoint - A lawsuit has been filed against Lineage, Inc. and its senior executives for potential violations of federal securities laws related to its IPO and subsequent financial performance [1][2]. Group 1: Lawsuit Details - Investors have until September 30, 2025, to request to lead the case, which is based on claims under Sections 11 and 15 of the Securities Act of 1933 [2]. - The lawsuit is pending in the U.S. District Court for the Eastern District of Michigan, specifically titled City of St. Clair Shores Police and Fire Retirement System v. Lineage, Inc., et al. [2]. Group 2: Company Overview - Lineage, Inc. operates as a cold storage-focused real estate investment trust (REIT), owning and managing temperature-controlled storage facilities for perishable products [3]. Group 3: Allegations and Financial Performance - The IPO documents claimed that Lineage had "consistent cold chain demand" and strong cash flows, suggesting resilience during economic stress, while the reality was a downturn due to customers destocking excess inventory from the pandemic [4]. - Following the IPO on July 25, 2024, at $78 per share, Lineage's stock price has significantly declined to around $40 per share, approximately 50% of its initial value [5].

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Dow Inc. for possible violations of federal securities laws and unlawful business practices, following a significant drop in Dow's stock price after disappointing financial results [2][3]. Financial Performance - Dow reported net sales of $10.1 billion for Q2 2025, which represents a 7% decrease year-over-year and a 3% decline sequentially. The decline was attributed to reduced performance across all operating segments, despite some seasonal demand in Performance Materials & Coatings [3]. Stock Price Reaction - Following the announcement of its financial results, Dow's stock price fell by $5.30 per share, equating to a 17.45% drop, closing at $25.07 per share on July 24, 2025 [3]. Legal Investigation - The law firm is encouraging investors who suffered losses in Dow's stock to reach out for discussions regarding their legal rights and potential claims [1][4].